IP Library Granted Patent US 9,863,010
Granted Patent B2
US 9,863,010 · App. 15/012,096 · Granted Jan 9, 2018

Compositions, methods and kits to detect adenovirus nucleic acids

Inventors: Emily Ziegler (Milwaukee, WI); Jessica Townsend (Milwaukee, WI)
C12Q1/701C07H21/02C07H21/04C12Q2600/158C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,863,010
App. No.
15/012,096
Granted
Jan 9, 2018
Kind
B2
Abstract

The disclosed invention is related to methods, compositions, kits and isolated nucleic acid sequences for targeting Adenovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers.

Claims (31)

1. A method for detecting an Adenovirus nucleic acid comprising the steps of:

(a) contacting a test sample comprising nucleic acid with at least one hybridization assay probe having a nucleotide sequence consisting of a sequence selected from the group consisting of SEQ ID NOs: 10, 19, 21, 23, 24, 29, 36, and 37 or a combination of two or more thereof; and

(b) determining if a probe:target duplex has formed under stringent hybridization conditions in the test sample,

wherein the presence of the probe:target duplex is an indication of the presence of Adenovirus nucleic acid in the test sample.

2. The method of claim 1 , wherein the hybridization assay probe sequence consists of SEQ ID NO:10.

3. The method of claim 2 , wherein the contacting step further comprises contacting the test sample with a combination of at least two amplification oligomers wherein the combination comprises target hybridizing sequences of SEQ ID NOs:5 & 6, or SEQ ID NOs:5 & 8.

4. The method of claim 1 , wherein the hybridization assay probe comprises the sequence consisting of SEQ ID NO:19.

5. The method of claim 4 , wherein the contacting step further comprises contacting the test sample with a combination of at least two amplification oligomers wherein the combination comprises a first amplification oligomer comprising a target hybridizing sequence selected from SEQ ID NOs:11 & 12, and a second amplification oligomer comprising a target hybridizing sequence selected from SEQ ID NOs:13 & 15.

6. The method of claim 5 , wherein the hybridization assay probe is a Taqman probe comprising the sequence consisting of SEQ ID NO:19, a fluorophore attached to the sequence and a quencher attached to the sequence.

7. The method of claim 6 , wherein the first amplification oligomer comprises a target hybridizing sequences consisting of SEQ ID NO:12.

8. The method of claim 6 , wherein the second amplification oligomer comprises a target hybridizing sequences consisting of SEQ ID NO:15.

9. The method of claim 1 , wherein the at least one hybridization assay probe is a combination of two hybridization assay probes, one of which comprises a sequence consisting of SEQ ID NO:21 and the other of which comprises a sequence consisting of SEQ ID NO:24.

10. The method of claim 9 , wherein each of the two hybridization assay probes further comprises a fluorophore and a quencher attached to the sequence.

11. The method of claim 9 , wherein the contacting step further comprises contacting the test sample with a combination of at least two amplification oligomers wherein the combination comprises target hybridizing sequences of SEQ ID NOs:12 & 15.

12. The method of claim 1 , wherein the contacting step further comprises contacting the test sample with a combination of at least two amplification oligomers, and wherein the combination of at least two amplification oligomers and at least one hybridization assay probe comprises the sequences of:

(i) SEQ ID NOs: 21, 23, 25, 26, 27, & 28;

(ii) SEQ ID NOs:21, 23, 26, 27, & 28;

(iii) SEQ ID NOs:21, 23, 25, 27, & 28;

(iv) SEQ ID NOs:21, 23, 25, 26, & 28;

(v) SEQ ID NOs:21, 23, 25, 26, & 27;

(vi) SEQ ID NOs:23, 25, 26, 27, & 28;

(vii) SEQ ID NOs:25, 26, 27, 28, & 29;

(viii) SEQ ID NOs:21, 23, 27, 28, 33, & 34;

(ix) SEQ ID NOs:21, 23, 27, 28, 33, & 35;

(x) SEQ ID NOs:21, 23, 27, 28, 34, & 35; or

(xii) SEQ ID NOs:25, 26, 27, 28, 36, & 37.

13. The method of claim 12 , wherein each of the at least one hybridization assay probe sequences further comprises a fluorophore attached to the sequence.

14. The method of claim 13 , wherein each of the at least one hybridization assay probe sequences further comprises a quencher attached to the sequence.

15. A composition for use in detecting an Adenovirus target nucleic acid, wherein the composition comprises at least one hybridization assay probe comprising (A) a sequence selected from the group consisting of SEQ ID Nos. 10, 19, 21, 23, 24, 29, 36, and 37 or a combination of two or more thereof, and (B) a label attached to the sequence.

16. The composition of claim 15 , wherein the label is a fluorophore.

17. The composition of claim 16 , wherein the at least one hybridization assay probe further comprises a quencher that is attached to the sequence.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 038499/0134 Recorded Apr 23, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED
Reel/Frame 075468/0001 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 043523 FRAME: 0907. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Dec 4, 2017
From: ZIEGLER, EMILY L.; TOWNSEND, JESSICA
To: GEN-PROBE PRODESSE, INC.
Reel/Frame 044679/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ZIEGLER, EMILY L.; TOWNSEND, JESSICA A.
To: GEN-PROBE INCORPORATED
Reel/Frame 043523/0907 →
SECURITY AGREEMENT Recorded Apr 22, 2016
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 038499/0134 →
Continuity (3)
Continuation 14220466 · Mar 20, 2014
Division 13253819 · Oct 5, 2011
Related Publication 20170002430A1 · Jan 5, 2017